Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans

亨德拉病毒感染是一种严重的，往往是致命的疾病。亨德拉感染没有治愈方法，现有的治疗方法无效。最近，一种人单克隆抗体在保护动物免受疾病发展方面显示出巨大的希望。该项目旨在进行临床前安全性测试和I期临床试验，以确定该抗体的安全性，使其可用于预防暴露于该疾病的人类的亨德拉感染。

Hendra virus infection in humans is a serious, and often fatal, disease. No cure exists for Hendra infection and existing treatments are ineffective. Recently, a human monoclonal antibody has shown great promise in protecting animals from developing the disease. This project aims to perform preclinical safety testing and a Phase I clinical trial to establish the safety profile of this antibody such that it can be used to prevent Hendra infection in humans exposed to the disease.